.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Cantor Fitzgerald
McKesson
Harvard Business School
Queensland Health
US Army
Cerilliant
Argus Health
Fish and Richardson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Plx Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for PLX PHARMA, and when can generic versions of PLX PHARMA drugs launch?

PLX PHARMA has one approved drug.

There are five US patents protecting PLX PHARMA drugs.

There are twenty-nine patent family members on PLX PHARMA drugs in eighteen countries and two supplementary protection certificates in two countries.

Summary for Plx Pharma

International Patents:29
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Plx PharmaASPIRINaspirinCAPSULE;ORAL203697-001Jan 14, 2013OTCYesYes► Subscribe► Subscribe► Subscribe
Plx PharmaASPIRINaspirinCAPSULE;ORAL203697-001Jan 14, 2013OTCYesYes► Subscribe► SubscribeY► Subscribe
Plx PharmaASPIRINaspirinCAPSULE;ORAL203697-001Jan 14, 2013OTCYesYes► Subscribe► SubscribeY► Subscribe
Plx PharmaASPIRINaspirinCAPSULE;ORAL203697-001Jan 14, 2013OTCYesYes► Subscribe► SubscribeY► Subscribe
Plx PharmaASPIRINaspirinCAPSULE;ORAL203697-001Jan 14, 2013OTCYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Plx Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,911,752Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity► Subscribe
9,730,884pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same► Subscribe
9,687,551Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Plx Pharma Drugs

Country Document Number Estimated Expiration
China1543358► Subscribe
China102258457► Subscribe
Cyprus1110474► Subscribe
Canada2431606► Subscribe
Japan2014531460► Subscribe
World Intellectual Property Organization (WIPO)02085414► Subscribe
Australia2001297778► Subscribe
Germany60136647► Subscribe
Canada2850187► Subscribe
South Korea20140105436► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Plx Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012000017Germany► SubscribePRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
12/048Ireland► SubscribePRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Harvard Business School
Teva
Johnson and Johnson
Citi
Novartis
Fish and Richardson
Chinese Patent Office
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot